Osmosis video - Protease inhibitors

00:00 / 00:00
More Videos

04:07
Mechanisms of antibiotic resistance

10:46
Antimetabolites: Sulfonamides and trimethoprim

15:13
Antituberculosis medications

15:07
Cell wall synthesis inhibitors: Cephalosporins

13:49
Cell wall synthesis inhibitors: Penicillins

07:11
DNA synthesis inhibitors: Fluoroquinolones

05:24
DNA synthesis inhibitors: Metronidazole

15:09
Miscellaneous cell wall synthesis inhibitors

16:32
Miscellaneous protein synthesis inhibitors

11:25
Protein synthesis inhibitors: Aminoglycosides

10:45
Protein synthesis inhibitors: Tetracyclines
Video Summary of Protease inhibitors
Protease inhibitors (PIs) are a class of antiviral drugs that are widely used to manage HIV/AIDS. Protease inhibitors prevent viral replication by selectively binding the enzyme HIV-1 protease, and prevent the formation of new viruses and further infection of the host's cells. Common medications in this class include atazanavir, darunavir, indinavir, lopinavir, tipranavir, and ritonavir. Common side effects of protease inhibitors include gastrointestinal problems such as diarrhea, nausea, and vomiting; and metabolic disorders such as hyperglycemia, insulin resistance, and hyperlipidemia.